Sen. Hassan Presses Pharmaceutical CEOs on Using 'Gimmicks & Loopholes' to Keep Medication Prices Sky-High
February 09, 2024
February 09, 2024
WASHINGTON, Feb. 9 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
Today, Senator Maggie Hassan pressed CEOs of three major pharmaceutical companies - Johnson & Johnson, Merck, and Bristol Myers Squibb (BMS) - about their sky-high prices for prescription drugs at a Senate Health, Education, Labor, and Pensions Committee hearing.
First, Senator Hassan challenged Robert Davis, CEO of Merck - whose cancer medication Keytruda has an annual lis . . .
Today, Senator Maggie Hassan pressed CEOs of three major pharmaceutical companies - Johnson & Johnson, Merck, and Bristol Myers Squibb (BMS) - about their sky-high prices for prescription drugs at a Senate Health, Education, Labor, and Pensions Committee hearing.
First, Senator Hassan challenged Robert Davis, CEO of Merck - whose cancer medication Keytruda has an annual lis . . .